Renal Stone Recurrence Risk Assessment
Identifies risk factors for renal stone recurrence to guide metabolic evaluation and preventive treatment.
Score interpretation
→ General advice: high fluid intake (>2.5L/day); dietary modification; no detailed metabolic work-up needed for first stone
→ Metabolic evaluation: 24h urine (oxalate, calcium, uric acid, citrate, pH); stone analysis; targeted prevention
→ Full metabolic work-up; specialist urology/nephrology referral; pharmacological prevention (thiazides, allopurinol, citrate, D-penicillamine for cystine)
Interpretation bands for the Stone Recurrence Risk. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Allopurinol · Xanthine Oxidase Inhibitor — Uric Acid Stone Prevention
- Hydrochlorothiazide · Thiazide Diuretic — Calcium Stone Prevention
- Folinic Acid (Calcium Folinate / Leucovorin) · Antidote / Chemotherapy Support
- Folinic Acid (Calcium Folinate / Leucovorin) · Antidote / Chemotherapy Support
- Folinic acid (calcium folinate) · Reduced folate
- Levofolinic acid (calcium levofolinate) · Reduced folate (active enantiomer of folinic acid)
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.